Eric Yarnell, ND, RH(AHG) 2012

Size: px
Start display at page:

Download "Eric Yarnell, ND, RH(AHG) 2012"

Transcription

1 Benign Prostatic Hyperplasia Eric Yarnell, ND, RH(AHG) IPSS Questionnaire Useful clinical tool Freely available Well validated Available in many languages Gives some objective support for what we do Allows comparison to other tx 2 Measures Postvoid residual (PVR) urine Maximum flow rate (Qmax) Red flag symptoms Acute urine retention (AUR) Urinary tract infections (UTI) Acute renal failure (ARF) 3 When to Treat IPSS >8 and patient is bothered Qmax <6-7 ml/sec PVR >100 ml Worsening symptoms History of acute retention (!), ARF (!!), other severe complications 4

2 = Secretory epithelium and duct 2 = Stroma (fibroblasts, smooth muscle cells) 5 Types of BPH Stromal Epithelial Mixed CT, smooth muscle Second most common Epithelium Least common Both Most common Spasm Sheer size Spasm and size Less hormonal More hormonal Mixed hormonal 6 Stromal BPH 7 Key Features Irritative symptoms: Nocturia Frequency Urgency Prostate tends to be small (<40 g) Metabolic syndrome (not always) 8

3 CH 3 Herbs vs. Drugs Spasmolytic Herbs Ammi v, Piper m, Pedicularis, Gelsemium, Valeriana, etc. Mixed actions Relatively cheap Alpha Blocker Drugs tamsulosin, alfuzosin, terazosin Alpha-1 Adrenergic Antagonists New drugs expensive, old ones cheap 3-4 x/d dosing 1-2 x/d dosing Minimal adverse effects; sleepiness (rare) Retrograde ejaculation, hypotension, asthenia 9 khellin CH 3 visnadine Ammi visnaga (khella) 10 Piper methysticum (kava) Photo 2012 D. Howell used with permission 11 Photo 2012 Heron Botanicals Used with permission 12

4 Patient utcome BfArM MCA Tx duration Kavapyrones (months) (mg/d) 39 f good f 24 up to 210 good f good f lethal f good f good f 7 60 liver transplant f liver transplant, lethal +/ f?? good?? 56 f?? good m two liver transplants m good f several 120 good f liver cirrhosis f good f 0.25? good +/ f liver transplant, lethal f 6? liver transplant f 6 60 good f liver transplant ++ + Table 1 from Phytomedicine 2003;10: Compare Acetaminophen FDA required warning 2006, Severe liver damage may occur, worse with ethanol (further intensified 2009) 50% of acute liver failure in US due to acetaminophen Clin Toxicol 2009;47: Pedicularis bracteosa Louseworts Pedicularis racemosa 15 Viburnum opulus (crampbark) 16

5 Valeriana sitchensis (Sitka valerian) Photo 2012 Heron Botanicals Used with permission 17 Gelsemium sempervirens Photo 2012 Howell Used with permission 18 Pulsati!a occidentalis (western pasque flower) 19 Pedicularis bracteosa (or Piper methysticum) Base Formula Lead spasmolytic 30-55% Ammi visnaga (or Gelsemium*) Fouquieria splendens (or Ceanothus) Supporting spasmolytic Supporting pelvic lymphagogue 20-40% 5-10% Glycyrrhiza glabra (or Zingiber) * Max 1 ml/dose Synergizer 5-10% 1 tsp tid (last dose hs) 20

6 Avoid Diuretics 21 Serenoa repens Creative Commons license 22 The Big Negative Study Bent, et al (published in N Engl J Med of course) n = 225, 1 yr, double-blind v placebo Moderate-to-severe BPH (!) Bottom line: Study population not same as other trials 23 Long-Term Studies Pytel 2002 pen; n = 155 Lopatkin 2007 Djavan 2005 pen; n = 219 pen; n = mg bid 2 yr 160 mg bid (w/ Urtica) 1.8 yr 320 mg qd 2 yr Pierre pen; n = 160 mg bid 2 yr Fabre Effective for sx Effective for sx Effective for sx & worsening Effective for sx 24

7 Effect on 5α-Reductase Testosterone Dihydrotestosterone (DHT) 5α-Reductase 50% inhibition Serenoa extract 50% reduction Epidermal Growth Factor (EGF) Prostate 1998;37: Comparative Effect on 5α-Reductase Testosterone Dihydrotestosterone (DHT) 5α-Reductase 32% inhibition 80% inhibition Serenoa extract Finasteride Urology 2001;57: Molecular Targets for Serenoa Testosterone 5α-Reductase DHT Sex Hormone Binding Globulin Estrogens Aromatase Androgen Receptor Estrogen Receptor DNA SHBG Receptor Growth Factors (eg EGF) Prostatic Hyperplasia Receptors (eg EGFR) Catecholamines α2 Adrenergic Receptors Tissue spasm 27 Hormonal BPH 28

8 Hormonal BPH Theory: excess estrogens Result: prostate size 50 cc Predominant sx: Weak stream (low Qmax) Hesitancy, dribbling Incomplete emptying (high PVR) ften mixed with spasmotic BPH Much harder to treat naturally 29 Herbs vs Drugs Hormone-Modulating Herbs Polygonum, Epimedium, Serenoa, Nuphar, etc. Poorly tested (mostly) Very safe Unknown effect on prostate cancer 5-a-Reductase Inhibitor Drugs finasteride, dutasteride Well tested, only help if prostate >50 g Low libido, ED common Known to mildly reduce risk of prostate cancer 30 Polygonum multiflorum (he shou wu) 31 Polygonum multiflorum (he shou wu) Photo 2012 Heron Botanicals Used with permission 32

9 Epimedium grandiflorum (yin yang huo) 33 Pueraria montana var lobata (kudzu) 34 Legume Psoralea corylifolia (blackdot) Genistein (ppm) Daidzein (ppm) Kudzu Yellow split pea Black beans Baby limas Anasazi Soy Pinto Fava 20 5 J Altern Complement Med 1997;3: Public domain Nuphar polysepalum (yellow pond lily) 36

10 Photo 2012 Heron Botanicals Used with permission Nuphar polysepalum (yellow pond lily) 37 Aconitum spp (aconite) Photo 2012 G. Maroney Used with permission 38 Urtica dioica 39 Molecular Targets for Urtica Testosterone 5α-Reductase DHT Sex Hormone Binding Globulin Estrogens Aromatase Androgen Receptor Estrogen Receptor DNA SHBG Receptor Growth Factors (eg EGF) Prostatic Hyperplasia Receptors (eg EGFR) Amer. Herbal Pharmacopoeia Catecholamines α2 Adrenergic Receptors Tissue spasm 40

11 Treatment Regardless of Type 41 Diet and Lifestyle At least some vegan days (or pescovegan) rganic, free-range animal products Phytoestrogenic foods Regular exercise Avoid estrogenic chemicals 42 Phytoestrogens Lower doses act as estrogen antagonists Linum usitatissimum (flax) Pueraria lobata (kudzu) Trifolium spp (red clover, etc.) Complex actions 43 3rd Int Consultation on BPH, Paris

12 Avoid Xenoestrogens Phthalates Parabens Bisphenol A Atrazine Lindane DDT Nonylphenyl 45

Benign Prostatic Hyperplasia. Jay Lee, MD, FRCSC Clinical Associate Professor University of Calgary

Benign Prostatic Hyperplasia. Jay Lee, MD, FRCSC Clinical Associate Professor University of Calgary Benign Prostatic Hyperplasia Jay Lee, MD, FRCSC Clinical Associate Professor University of Calgary Copyright 2017 by Sea Courses Inc. All rights reserved. No part of this document may be reproduced, copied,

More information

MANAGING BENIGN PROSTATIC HYPERTROPHY IN PRIMARY CARE DR GEORGE G MATHEW CONSULTANT FAMILY PHYSICIAN FELLOW IN SEXUAL & REPRODUCTIVE HEALTH

MANAGING BENIGN PROSTATIC HYPERTROPHY IN PRIMARY CARE DR GEORGE G MATHEW CONSULTANT FAMILY PHYSICIAN FELLOW IN SEXUAL & REPRODUCTIVE HEALTH MANAGING BENIGN PROSTATIC HYPERTROPHY IN PRIMARY CARE DR GEORGE G MATHEW CONSULTANT FAMILY PHYSICIAN FELLOW IN SEXUAL & REPRODUCTIVE HEALTH INTRODUCTION (1) Part of male sexual reproductive organ Size

More information

Benign Prostatic Hyperplasia (BPH):

Benign Prostatic Hyperplasia (BPH): Benign Prostatic Hyperplasia (BPH): Evidence Based Guidelines for Primary Care Providers Jeanne Martin, DNP, ANP-BC Objectives 1. Understand the pathophysiology and prevalence of BPH 2. Select the appropriate

More information

Victoria Sharp, MD, MBA, FAAFP. Clinical Professor of Urology and Family Medicine

Victoria Sharp, MD, MBA, FAAFP. Clinical Professor of Urology and Family Medicine Victoria Sharp, MD, MBA, FAAFP Clinical Professor of Urology and Family Medicine Victoria Sharp, MD, MBA, FAAFP Market Chief Medial Officer AmeriHealth Caritas Family of Companies Office phone: (515) 330-3740

More information

Increasing Awareness, Diagnosis, and Treatment of BPH, LUTS, and EP

Increasing Awareness, Diagnosis, and Treatment of BPH, LUTS, and EP Introduction to Enlarged Prostate E. David Crawford, MD Professor of Surgery (Urology) and Radiation Oncology Head, Urologic Oncology E. David Crawford Endowed Chair in Urologic Oncology University of

More information

Role of herbal drugs in the management of benign prostatic hyperplasia: Clinical trial to evaluate the efficacy and safety of Himplasia

Role of herbal drugs in the management of benign prostatic hyperplasia: Clinical trial to evaluate the efficacy and safety of Himplasia [Medicine Update (2003): 11(2), 55-58] Role of herbal drugs in the management of benign prostatic hyperplasia: Clinical trial to evaluate the efficacy and safety of Himplasia Arora, R.P., CMO, Rajiba L.

More information

Management of LUTS. Simon Woodhams February 2012

Management of LUTS. Simon Woodhams February 2012 Management of LUTS Simon Woodhams February 2012 The management of lower urinary tract symptoms (LUTS) in men Implementing NICE guidance May 2010 NICE clinical guideline 97 Background Lower urinary tract

More information

The Journal of International Medical Research 2012; 40:

The Journal of International Medical Research 2012; 40: The Journal of International Medical Research 2012; 40: 899 908 Comparison of α-blocker Monotherapy and α-blocker Plus 5α-Reductase Inhibitor Combination Therapy Based on Prostate Volume for Treatment

More information

Elements for a Public Summary

Elements for a Public Summary VI.2 VI.2.1 Elements for a Public Summary Overview of disease epidemiology Benign prostatic hyperplasia (BPH), also called benign prostatic hypertrophy or benign prostatic obstruction, is a condition in

More information

The Evolution of Combination Therapy. US men eligible for BPH treatment * with projected population changes

The Evolution of Combination Therapy. US men eligible for BPH treatment * with projected population changes The Management of BPH & The Impact of Combination Therapy Results Combination of Avodart and Tamsulosin (CombAT) Medical Therapy of Prostate Symptoms (MTOPS) Dr. Jack Barkin, md, fics, facs, dabu, Mcert

More information

10/9/2015. Dana A. Brown, Pharm.D., BCPS Assistant Dean for Academics, Associate Professor of Pharmacy Practice Palm Beach Atlantic University

10/9/2015. Dana A. Brown, Pharm.D., BCPS Assistant Dean for Academics, Associate Professor of Pharmacy Practice Palm Beach Atlantic University Dana A. Brown, Pharm.D., BCPS Assistant Dean for Academics, Associate Professor of Pharmacy Practice Palm Beach Atlantic University 1. Explain the pathophysiology of benign prostatic hyperplasia (BPH),

More information

MEDICAL THERAPY. Endocrine Approaches. Página 1 de 5.

MEDICAL THERAPY. Endocrine Approaches. Página 1 de 5. Página 1 de 5 MEDICAL THERAPY Part of "32 - BENIGN PROSTATIC HYPERPLASIA" Use of pharmacologically defined and a variety of so-called alternative medications to attempt to improve BPH voiding dysfunction

More information

Benign Prostatic Hyperplasia. Shahideh Amini Pharm.D clinical pharmacy resident Tehran university of medical science Department of pharmacotherapy

Benign Prostatic Hyperplasia. Shahideh Amini Pharm.D clinical pharmacy resident Tehran university of medical science Department of pharmacotherapy Benign Prostatic Hyperplasia Shahideh Amini Pharm.D clinical pharmacy resident Tehran university of medical science Department of pharmacotherapy Definition BPH is a common disorder that increases in frequency

More information

Prostate Disease. Chad Baxter, MD

Prostate Disease. Chad Baxter, MD Prostate Disease Chad Baxter, MD Managing BPH and LUTS Chad Baxter, MD Department of Urology cbaxter@mednet.ucla.edu 33 nd Annual UCLA Intensive Course in Geriatric Medicine & Board Review Prevalence of

More information

Combination Drug Therapy for Benign Prostatic Hyperplasia (BPH)

Combination Drug Therapy for Benign Prostatic Hyperplasia (BPH) The Annals of African Surgery www.sskenya.org Combination Drug Therapy for Benign Prostatic Hyperplasia (BPH) Author: Oliech J.S. FRCS, Affiliation: Department of Surgery, University of Nairobi. P.O. Box

More information

EVALUATION OF THE EFFICACY OF TADALAFIL IN IMPROVING LOWER URINARY TRACT SYMPTOMS IN PATIENTS WITH SYMPTOMATIC BENIGN PROSTATIC ENLARGEMENT

EVALUATION OF THE EFFICACY OF TADALAFIL IN IMPROVING LOWER URINARY TRACT SYMPTOMS IN PATIENTS WITH SYMPTOMATIC BENIGN PROSTATIC ENLARGEMENT Basrah Journal Of Surgery EVALUATION OF THE EFFICACY OF TADALAFIL IN IMPROVING LOWER URINARY TRACT SYMPTOMS IN PATIENTS WITH SYMPTOMATIC BENIGN PROSTATIC ENLARGEMENT MB, ChB, FIBMS, Assistant Professor

More information

Mini-Invasive Treatment in Urological Diseases Dott. Alberto Saita Responsabile Endourologia Istituto Clinico Humanitas - Rozzano

Mini-Invasive Treatment in Urological Diseases Dott. Alberto Saita Responsabile Endourologia Istituto Clinico Humanitas - Rozzano Dipartimento di Urologia Direttore Prof. Giorgio Guazzoni Mini-Invasive Treatment in Urological Diseases Dott. Alberto Saita Responsabile Endourologia Istituto Clinico Humanitas - Rozzano alberto.saita@humanitas.it

More information

Frank P. Begun, M.D. Associate Professor, Urology

Frank P. Begun, M.D. Associate Professor, Urology Benign Prostate Disorders Frank P. Begun, M.D. Associate Professor, Urology Medical Director, Urological Services at OSU East Hospital The Ohio State University Objectives/Goals To understand the causes

More information

Case studies: LUTS. Case 1 history. Case 1 - questions. Case 1 - outcome. Case 2 - history. Case 1 learning point 14/07/2015 DR JON REES

Case studies: LUTS. Case 1 history. Case 1 - questions. Case 1 - outcome. Case 2 - history. Case 1 learning point 14/07/2015 DR JON REES Case 1 history Case studies: LUTS DR JON REES A 49 year old male comes to see you he has had gradual deterioration of his flow over the last few years- he saw a colleague of yours 6 weeks ago who recorded

More information

Prostate Health PHARMACIST VIEW

Prostate Health PHARMACIST VIEW Prostate Health PHARMACIST VIEW Prostate Definition Prostate is a gland made of fibromuscular tissue. It is about 4 cm and surrounds the neck of the bladder and the urethra. It produces seminal fluid.

More information

PROSTATIC ARTERY EMBOLISATION (PAE) FOR BENIGN PROSTATIC HYPERPLASIA. A Minimally Invasive Innovative Treatment

PROSTATIC ARTERY EMBOLISATION (PAE) FOR BENIGN PROSTATIC HYPERPLASIA. A Minimally Invasive Innovative Treatment PROSTATIC ARTERY EMBOLISATION (PAE) FOR BENIGN PROSTATIC HYPERPLASIA A Minimally Invasive Innovative Treatment What is the prostate? The prostate is an accessory organ of the male reproductive system.

More information

Lower Urinary Tract Symptoms (LUTS) and Nurse-Led Clinics. Sean Diver Urology Advanced Nurse Practitioner candidate Letterkenny University Hospital

Lower Urinary Tract Symptoms (LUTS) and Nurse-Led Clinics. Sean Diver Urology Advanced Nurse Practitioner candidate Letterkenny University Hospital Lower Urinary Tract Symptoms (LUTS) and Nurse-Led Clinics Sean Diver Urology Advanced Nurse Practitioner candidate Letterkenny University Hospital 01/02/2018 Lower Urinary Tract Symptoms LUTS - one of

More information

PRABHAKAR SINGH*, MANOJ INDURKAR, AMITA SINGH, PALLAVI INDURKAR

PRABHAKAR SINGH*, MANOJ INDURKAR, AMITA SINGH, PALLAVI INDURKAR Academic Sciences International Journal of Current Pharmaceutical Research ISSN- 0975-7066 Vol 5, Issue 1, 2013 Research Article COMPARISON OF THE EFFICACY AND SAFETY OF TAMSULOSIN (0.4 V/S (and) FINASTERIDE

More information

During the past decade, numerous

During the past decade, numerous Benign prostatic hyperplasia (BPH) is one of the most common diseases of aging men. It is estimated that by age 60 years, greater than 50% of men will have histologically documented evidence of the disease.

More information

Benign Prostatic Hyperplasia (BPH) Important Papers / Landmark. Vijayan Manogran

Benign Prostatic Hyperplasia (BPH) Important Papers / Landmark. Vijayan Manogran Benign Prostatic Hyperplasia (BPH) Important Papers / Landmark Studies Vijayan Manogran MTOPS & CombAT PLESS SMART ALTESS ALF-ONE VA PREDICT EPICS Landmark Studies MTOPS Medical Therapy of Prostatic Symptoms

More information

Office Management of Benign Prostatic Enlargement

Office Management of Benign Prostatic Enlargement Focus on CME at McGill University Office Management of Benign Prostatic Enlargement Symptomatic benign prostate enlargement is a common medical problem encountered in our aging society. Watchful waiting,

More information

Benign Prostatic Hyperplasia. Management of Benign Prostatic Hyperplasia. Goals of Therapy

Benign Prostatic Hyperplasia. Management of Benign Prostatic Hyperplasia. Goals of Therapy Benign Prostatic Hyperplasia Management of Benign Prostatic Hyperplasia Goals of Therapy Improve or abolish lower urinary tract symptoms (LUTS) Prevent or delay clinical progression of benign prostatic

More information

New Treatment Modalities for Benign Prostatic Hyperplasia. Seung-June Oh, MD Department of Urology, Seoul National University Hospital

New Treatment Modalities for Benign Prostatic Hyperplasia. Seung-June Oh, MD Department of Urology, Seoul National University Hospital New Treatment Modalities for Benign Prostatic Hyperplasia Seung-June Oh, MD Department of Urology, Seoul National University Hospital Options for Treating BPH Pharmacotherapy blocker Agents for BPH + OAB

More information

H6D-MC-LVHR Clinical Study Report Synopsis Page LVHR Synopsis (LY450190)

H6D-MC-LVHR Clinical Study Report Synopsis Page LVHR Synopsis (LY450190) H6D-MC-LVHR Clinical Study Report Synopsis Page 1 2. LVHR Synopsis H6D-MC-LVHR Clinical Study Report Synopsis Page 2 Clinical Study Report Synopsis: Study H6D-MC-LVHR Title of Study: A Randomized, Double-Blind,

More information

MMM. Topic The use of Tadalafil 5mg daily for the treatment of BPH-LUTS

MMM. Topic The use of Tadalafil 5mg daily for the treatment of BPH-LUTS Dr Tan & Partners MMM Vol. 1 No. 1 Morbidity & Mortality Meeting 14 th November 2014 Introduction Topic The use of Tadalafil 5mg daily for the treatment of BPH-LUTS Tadalafil 5mg daily is a well established

More information

LONG-TERM SAFETY AND EFFICACY OF TAMSULOSIN FOR THE TREATMENT OF LOWER URINARY TRACT SYMPTOMS ASSOCIATED WITH BENIGN PROSTATIC HYPERPLASIA

LONG-TERM SAFETY AND EFFICACY OF TAMSULOSIN FOR THE TREATMENT OF LOWER URINARY TRACT SYMPTOMS ASSOCIATED WITH BENIGN PROSTATIC HYPERPLASIA 0022-5347/03/1702-0498/0 Vol. 170, 498 502, August 2003 THE JOURNAL OF UROLOGY Printed in U.S.A. Copyright 2003 by AMERICAN UROLOGICAL ASSOCIATION DOI: 10.1097/01.ju.0000076140.68657.fd LONG-TERM SAFETY

More information

(dutasteride/tamsulosin) For the treatment of Benign Prostatic Hyperplasia (BPH)

(dutasteride/tamsulosin) For the treatment of Benign Prostatic Hyperplasia (BPH) Combodart (dutasteride/tamsulosin) For the treatment of Benign Prostatic Hyperplasia (BPH) This leaflet is only for use by patients who have been prescribed Combodart. Please see Patient Information Leaflet

More information

Current drug management of BPH in primary care Claire Taylor MRCS, Charlotte Foley MRCS and Roger Kirby MA, MD, FRCS Urol

Current drug management of BPH in primary care Claire Taylor MRCS, Charlotte Foley MRCS and Roger Kirby MA, MD, FRCS Urol Drug review BPH Current drug management of BPH in primary care Claire Taylor MRCS, Charlotte Foley MRCS and Roger Kirby MA, MD, FRCS Urol Skyline Imaging Ltd The range of drug treatments for BPH, alone

More information

PROSTATIC EMBOLIZATION FOR BENIGN HYPERPLASIA

PROSTATIC EMBOLIZATION FOR BENIGN HYPERPLASIA St. Louis Hospital PROSTATIC EMBOLIZATION FOR BENIGN HYPERPLASIA INITIAL CLINICAL RESULTS Faculty of Medical Sciences New University of Lisbon JOÃO PISCO LUÍS CAMPOS PINHEIRO TIAGO BILHIM HUGO RIO TINTO

More information

Male Lower Urinary Tract Symptoms: Management in primary care and beyond. Daniel Cohen PhD FRCS(Urol) Consultant Urological Surgeon

Male Lower Urinary Tract Symptoms: Management in primary care and beyond. Daniel Cohen PhD FRCS(Urol) Consultant Urological Surgeon Male Lower Urinary Tract Symptoms: Management in primary care and beyond Daniel Cohen PhD FRCS(Urol) Consultant Urological Surgeon 1 LUTS Very common: 1/3 men over age of 50 have moderate to severe LUTS

More information

Benign Prostatic Hypertrophy (BPH) is the most

Benign Prostatic Hypertrophy (BPH) is the most Medical treatment of benign prostatic hypertrophy There is little doubt that medical therapy has transformed the treatment of benign prostatic hypertrophy (BPH). The medical treatment of BPH continues

More information

Key words: Lower Urinary Tract Symptoms (LUTS), Prostatic Hyperplasia, Alpha-1 Adrenoceptor Antagonists, Tamsulosin, Terazosin.

Key words: Lower Urinary Tract Symptoms (LUTS), Prostatic Hyperplasia, Alpha-1 Adrenoceptor Antagonists, Tamsulosin, Terazosin. The Professional Medical Journal DOI: 10.17957/TPMJ/17.4102 ORIGINAL PROF-4102 PROSTATIC HYPERPLASIA; COMPARISON BETWEEN TAMSULOSIN AND TERAZOSIN FOR EFFICACY IN MEDICAL MANAGEMENT OF LOWER URINARY TRACT

More information

Canadian Undergraduate Urology Curriculum (CanUUC): Prostate Diseases

Canadian Undergraduate Urology Curriculum (CanUUC): Prostate Diseases Canadian Undergraduate Urology Curriculum (CanUUC): Prostate Diseases LUTS/Benign Prostate Hyperplasia Objectives 1. List the lower urinary tract symptoms (LUTS) found in men with BPH. 2. List the differential

More information

Recommended drug treatment of BPH in primary care Claire Taylor MRCS, Charlotte Foley MRCS and Roger Kirby MA, MD, FRCS Urol

Recommended drug treatment of BPH in primary care Claire Taylor MRCS, Charlotte Foley MRCS and Roger Kirby MA, MD, FRCS Urol Drug review BPH Recommended drug treatment of BPH in primary care Claire Taylor MRCS, Charlotte Foley MRCS and Roger Kirby MA, MD, FRCS Urol Skyline Imaging Ltd The development of safe and effective drugs

More information

Chapter 3: Results of the Treatment Outcomes Analyses

Chapter 3: Results of the Treatment Outcomes Analyses Chapter 3: Results of the Treatment Outcomes Analyses TABLE OF CONTENTS INTRODUCTION... 3 WATCHFUL WAITING... 11 STUDY OUTCOMES... 11 MEDICAL THERAPIES... 13 ALPHA-ADRENERGIC ANTAGONISTS (ALPHA-BLOCKERS)...

More information

Voiding Dysfunction Block lecture, 5 th year student. Choosak Pripatnanont, Department of Surgery, PSU.

Voiding Dysfunction Block lecture, 5 th year student. Choosak Pripatnanont, Department of Surgery, PSU. Voiding Dysfunction 2009 Block lecture, 5 th year student. Choosak Pripatnanont, Department of Surgery, PSU. Objectives Understand and explain physiologic function and dysfunction of lower urinary tract.

More information

The Journal of International Medical Research 2005; 33:

The Journal of International Medical Research 2005; 33: The Journal of International Medical Research 2005; 33: 562 573 A Comparative Study on the Safety and Efficacy of Tamsulosin and Alfuzosin in the Management of Symptomatic Benign Prostatic Hyperplasia:

More information

Some prostatic diseases

Some prostatic diseases Some prostatic diseases Benign Prostatic Hyperplasia (Nodular Hyperplasia) Extremely common Present in a significant number of men by the age of 40 & its frequency rises progressively with age, reaching

More information

Benign Prostatic Hyperplasia (BPH) IPT VI Srikanth Kolluru, Ph.D

Benign Prostatic Hyperplasia (BPH) IPT VI Srikanth Kolluru, Ph.D Benign Prostatic yperplasia (BP) IPT VI Srikanth Kolluru, Ph.D. kolluru@tamhsc.edu, 361 221 0741 verview 1. Introduction and background of BP 2. Causes and common symptoms 3. Treatment options Learning

More information

What is Benign Prostatic Hyperplasia (BPH)?

What is Benign Prostatic Hyperplasia (BPH)? What is Benign Prostatic Hyperplasia (BPH)? Benign prostatic hyperplasia (BPH) is an enlarged prostate. The prostate goes through two main growth periods as a man ages. The first occurs early in puberty,

More information

Systematic Review of Combination Drug Therapy for Non-neurogenic Male Lower Urinary Tract Symptoms

Systematic Review of Combination Drug Therapy for Non-neurogenic Male Lower Urinary Tract Symptoms EUROPEAN UROLOGY 64 (2013) 228 243 available at www.sciencedirect.com journal homepage: www.europeanurology.com Platinum Priority Collaborative Review Benign Prostatic Hyperplasia Editorial by Herbert

More information

MODULE 3: BENIGN PROSTATIC HYPERTROPHY

MODULE 3: BENIGN PROSTATIC HYPERTROPHY MODULE 3: BENIGN PROSTATIC HYPERTROPHY KEYWORDS: Prostatic hypertrophy, prostatic hyperplasia, PSA, voiding dysfunction, lower urinary tract symptoms (LUTS) At the end of this clerkship, the medical student

More information

Lower Urinary Tract Symptoms K Kuruvilla Zachariah Associate Specialist

Lower Urinary Tract Symptoms K Kuruvilla Zachariah Associate Specialist Lower Urinary Tract Symptoms K Kuruvilla Zachariah Associate Specialist Lower Urinary Tract Symptoms Storage Symptoms Frequency, urgency, incontinence, Nocturia Voiding Symptoms Hesitancy, poor flow, intermittency,

More information

DIAGNOSED WITH BENIGN PROSTATIC HYPERPLASIA

DIAGNOSED WITH BENIGN PROSTATIC HYPERPLASIA Acta Poloniae Pharmaceutica ñ Drug Research, Vol. 74 No. 4 pp. 1247ñ1253, 2017 ISSN 0001-6837 Polish Pharmaceutical Society PHARMACOLOGY CLINICAL EVALUATION OF α-1-adrenolytics IN PATIENTS DIAGNOSED WITH

More information

Benign Prostatic Hyperplasia (BPH)

Benign Prostatic Hyperplasia (BPH) Benign Prostatic Hyperplasia (BPH) Definition Prostate gland enlargement is a common condition as men get older. Also called benign prostatic hyperplasia (BPH), prostate gland enlargement can cause bothersome

More information

Lower Urinary Tract Symptoms

Lower Urinary Tract Symptoms Advances in the management of BPH/LUTS Greetings from the Executive and Members of the European Association of Urology Christopher Chapple Professor of Urology Sheffield Hallam University Consultant Urological

More information

Urolithiasis. Types of Stones. Staghorn Stones. Eric Yarnell, ND, RH(AHG) Calcium monohydrate oxalate. Uric acid

Urolithiasis. Types of Stones. Staghorn Stones. Eric Yarnell, ND, RH(AHG) Calcium monohydrate oxalate. Uric acid Urolithiasis Eric Yarnell, ND, RH(AHG) 2012 1 Types of Stones Calcium monohydrate oxalate Uric acid Calcium dihydrate oxalate Struvite (Magnesium ammonium phosphate) Calcium phosphate 2 Staghorn Stones

More information

BPH OVERVIEW / MANAGEMENT. Richard L Haddad Norwest Private Hospital 17 Oct 2018

BPH OVERVIEW / MANAGEMENT. Richard L Haddad Norwest Private Hospital 17 Oct 2018 BPH OVERVIEW / MANAGEMENT Richard L Haddad Norwest Private Hospital 17 Oct 2018 Introduction Learning outcomes; Develop a management plan for BPH patients Describe the new medical therapies in BPH and

More information

Chapter 2: Methodology

Chapter 2: Methodology Chapter 2: Methodology TABLE OF CONTENTS Introduction... 2 Study Selection and Data Abstraction... 2 Data Synthesis... 8 Guideline Development and Approvals... 9 Conflict of Interest... 10 Copyright 2010

More information

VOIDING DYSFUNCTION IN ELDERLY MALE CURRENT STATUS

VOIDING DYSFUNCTION IN ELDERLY MALE CURRENT STATUS VOIDING DYSFUNCTION IN ELDERLY MALE CURRENT STATUS DR. FRANCIS LEE Voiding dysfunction Storage Emptying Common voiding dysfunction in elderly male Emptying BPH Storage Incontinence Overactive bladder Post-prostatectomy

More information

Diagnostic approach to LUTS in men. Prof Dato Dr. Zulkifli Md Zainuddin Consultant Urologist / Head Of Urology Unit UKM Medical Center

Diagnostic approach to LUTS in men. Prof Dato Dr. Zulkifli Md Zainuddin Consultant Urologist / Head Of Urology Unit UKM Medical Center Diagnostic approach to LUTS in men Prof Dato Dr. Zulkifli Md Zainuddin Consultant Urologist / Head Of Urology Unit UKM Medical Center Classification of LUTS Storage symptoms Voiding symptoms Post micturition

More information

All about the Prostate

All about the Prostate MEN S HEALTH Dr Nick Pendleton January 16 th 2018 All about the Prostate 1 What does it do? Functions of the Prostate 1. Secretes Prostatic Fluid slightly alkaline fluid, 30% of volume of seminal fluid,

More information

IJBCP International Journal of Basic & Clinical Pharmacology

IJBCP International Journal of Basic & Clinical Pharmacology Print ISSN: 2319-2003 Online ISSN: 2279-0780 IJBCP International Journal of Basic & Clinical Pharmacology DOI: http://dx.doi.org/10.18203/2319-2003.ijbcp20160772 Research Article Efficacy and safety of

More information

The Egyptian Journal of Hospital Medicine (January 2019) Vol. 74 (6), Page

The Egyptian Journal of Hospital Medicine (January 2019) Vol. 74 (6), Page The Egyptian Journal of Hospital Medicine (January 2019) Vol. 74 (6), Page 1377-1386 Evaluation of Silodosin in Comparison to Tamuslosin in Treatment of Benign Prostatic Hyperplasia with lower Urinary

More information

Double-Blind Placebo-Controlled Study of PR-2000 in the Management of Benign Prostatic Hyperplasia

Double-Blind Placebo-Controlled Study of PR-2000 in the Management of Benign Prostatic Hyperplasia [The Antiseptic (2002): (99), 1, 8-11] Double-Blind Placebo-Controlled Study of PR-2000 in the Management of Benign Prostatic Hyperplasia Garg, S.K., M.S., D.N.B. (Surgery), M.Ch., D.N.B. (Urology) Bombay

More information

Prostate Enlargement Reduction

Prostate Enlargement Reduction Executive Summary Prostate Enlargement Reduction Healthcare Supplement What is Prostate Enlargement? For most men, these nightly bathroom runs may be the first sign of an enlarged prostate. Other symptoms

More information

Silodosin versus naftopidil for the treatment of benign prostatic hyperplasia: A multicenter randomized trial

Silodosin versus naftopidil for the treatment of benign prostatic hyperplasia: A multicenter randomized trial The study protocol was approved by the ethics committee and institutional review board of Nihon University School of Medicine. Written informed consent was obtained from all patients. From December 2007

More information

Benign Prostatic Hyperplasia A Management Update for Pharmacists

Benign Prostatic Hyperplasia A Management Update for Pharmacists A Management Update for Pharmacists Tom Smiley, PharmD This program has been approved for 1.0 CEUs by the Canadian Council on Continuing Education in Pharmacy CCCEP #1043-2010-087-I-P This lesson is valid

More information

Two American Herbs: Saw Palmetto, Black Cohosh

Two American Herbs: Saw Palmetto, Black Cohosh Two American Herbs: Saw Palmetto, Black Cohosh Herbs as Medicine Plant medicines are the most widely used medicines in the world today. An estimated eighty percent (80%) of the world's population employs

More information

Urtica dioica for Treatment of Benign Prostatic Hyperplasia: A Prospective, Randomized, Double-Blind, Placebo-Controlled, Crossover Study

Urtica dioica for Treatment of Benign Prostatic Hyperplasia: A Prospective, Randomized, Double-Blind, Placebo-Controlled, Crossover Study Urtica dioica for Treatment of Benign Prostatic Hyperplasia: A Prospective, Randomized, Double-Blind, Placebo-Controlled, Crossover Study Mohammad Reza Safarinejad, MD ABSTRACT. Purpose: To determine the

More information

Index. urologic.theclinics.com. Note: Page numbers of article titles are in boldface type.

Index. urologic.theclinics.com. Note: Page numbers of article titles are in boldface type. Index Note: Page numbers of article titles are in boldface type. A Ablative therapies, transurethral needle ablation, Adverse events, sexual side effects of BPH Aging, and incidence of BPH associated with

More information

Prostate Artery Embolization: A Minimally Invasive Option for the Treatment of BPH

Prostate Artery Embolization: A Minimally Invasive Option for the Treatment of BPH Prostate Artery Embolization: A Minimally Invasive Option for the Treatment of BPH Farrah J. Wolf, MD Diagnostic Radiology, Board Certified Vascular & Interventional Radiology fwolf@bocaradiology.com Educational

More information

Overview. Urology Dine and Learn: Erectile Dysfunction & Benign Prostatic Hyperplasia. Iain McAuley September 15, 2014

Overview. Urology Dine and Learn: Erectile Dysfunction & Benign Prostatic Hyperplasia. Iain McAuley September 15, 2014 Urology Dine and Learn: Erectile Dysfunction & Benign Prostatic Hyperplasia Iain McAuley September 15, 2014 Overview Review of the most recent guidelines for ED and BPH ED Guidelines CUA 2006 AUA 2011

More information

As man draws near the common goal Can anything be sadder Than he who, master of his soul Is servant to his bladder LUTS 2. Prevalence of BPH LUTS 5

As man draws near the common goal Can anything be sadder Than he who, master of his soul Is servant to his bladder LUTS 2. Prevalence of BPH LUTS 5 BPH / LUTS Dr Jonny Coxon MA MD MRCS MRCGP DRCOG Beaconsfield Medical Practice, Brighton As man draws near the common goal Can anything be sadder Than he who, master of his soul Is servant to his bladder

More information

Men s Health Topics. Learning Objectives. BPH Definition. The Prostate Gland. I have nothing to disclose. Mindi Miller, Pharm. D.

Men s Health Topics. Learning Objectives. BPH Definition. The Prostate Gland. I have nothing to disclose. Mindi Miller, Pharm. D. I have nothing to disclose Men s Health 2016 Mindi Miller, Pharm. D., BCPS Topics Benign Prostatic Hyperplasia Erectile Dysfunction Learning Objectives Describe common lower urinary tract symptoms (LUTS)

More information

Original Article. Introduction. Methods. Abstract

Original Article. Introduction. Methods. Abstract Blackwell Science, LtdOxford, UKIJUInternational Journal of Urology0919-81722003 Blackwell Publishing Asia Pty LtdNovember 20031011587594Original ArticleUsefulness of a1-blockers in BPHI Ikemoto et al.

More information

We have new herb kits available!

We have new herb kits available! Your Monthly Update Dear Colleague Welcome to the May newsletter from Pure Bio Ltd. It has been a very busy couple of months for us! The one-day seminars that have been held to date have been fully booked

More information

Benign Prostatic Hyperplasia: Update on Innovative Current Treatments

Benign Prostatic Hyperplasia: Update on Innovative Current Treatments Benign Prostatic Hyperplasia: Update on Innovative Current Treatments Michael Ferrandino, MD As.soc Professor Director of Minimally Invasive Urologic Surgery Division of Urologic Surgery Duke University

More information

Causes of Transient Incontinence. Geriatrics: Urinary Incontinence, Dementia, and Delirium. Classification of Established Incontinence

Causes of Transient Incontinence. Geriatrics: Urinary Incontinence, Dementia, and Delirium. Classification of Established Incontinence Causes of Transient Geriatrics: Urinary, Dementia, and Delirium Carla Zeilmann, PharmD, BCPS St. Louis College of Pharmacy Therapeutics 3 Fall 2003 D delirium I infection A atrophic urethritis and vaginitis

More information

Prostate Health. What Is the Prostate?

Prostate Health. What Is the Prostate? Prostate Health Awareness of prostate health has come a long way since the days when comedians would confuse "prostate" with "prostrate." Yet, many men still aren't sure what the prostate is, what its

More information

α-blocker Monotherapy and α-blocker Plus 5-Alpha-Reductase Inhibitor Combination Treatment in Benign Prostatic Hyperplasia; 10 Years Long-Term Results

α-blocker Monotherapy and α-blocker Plus 5-Alpha-Reductase Inhibitor Combination Treatment in Benign Prostatic Hyperplasia; 10 Years Long-Term Results www.kjurology.org http://dx.doi.org/10.4111/kju.2012.53.4.248 Voiding Dysfunction α-blocker Monotherapy and α-blocker Plus 5-Alpha-Reductase Inhibitor Combination Treatment in Benign Prostatic Hyperplasia;

More information

Chapter 4: Research and Future Directions

Chapter 4: Research and Future Directions Chapter 4: Research and Future Directions Introduction Many of the future research needs listed in the 1994 Agency for Health Care Policy and Research (AHCPR) clinical practice guideline Benign Prostatic

More information

Index. urologic.theclinics.com. Note: Page numbers of article titles are in boldface type.

Index. urologic.theclinics.com. Note: Page numbers of article titles are in boldface type. Index Note: Page numbers of article titles are in boldface type. A Ablation, of prostate, holmium laser, 485 495 African prune tree (Pygeum africanum), 454 455 Alfuzosin, 445 446 Alpha-adrenergic agonists,

More information

Cialis. Cialis (tadalafil) Description

Cialis. Cialis (tadalafil) Description Federal Employee Program 1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 5.06.02 Subject: Cialis Page: 1 of 5 Last Review Date: September 18, 2015 Cialis Description Cialis (tadalafil)

More information

DOWNLOAD OR READ : TREATMENT OF BENIGN PROSTATIC HYPERPLASIA PDF EBOOK EPUB MOBI

DOWNLOAD OR READ : TREATMENT OF BENIGN PROSTATIC HYPERPLASIA PDF EBOOK EPUB MOBI DOWNLOAD OR READ : TREATMENT OF BENIGN PROSTATIC HYPERPLASIA PDF EBOOK EPUB MOBI Page 1 Page 2 treatment of benign prostatic hyperplasia treatment of benign prostatic pdf treatment of benign prostatic

More information

What can the primary care physician do? Brian W. Ellis

What can the primary care physician do? Brian W. Ellis What can the primary care physician do? Brian W. Ellis Consultant Urological Surgeon at Ashford & St Peter s 1983-2007 Currently Consultant Urological Surgeon at Cobham Hospital Visiting Professor at Middlesex

More information

The potential for NX-1207 in benign prostatic hyperplasia: an update for clinicians

The potential for NX-1207 in benign prostatic hyperplasia: an update for clinicians Therapeutic Advances in Chronic Disease Review The potential for NX-1207 in benign prostatic hyperplasia: an update for clinicians Neal Shore and Barrett Cowan Ther Adv Chronic Dis (2011) 2(6) 377 383

More information

JMSCR Vol 05 Issue 07 Page July 2017

JMSCR Vol 05 Issue 07 Page July 2017 www.jmscr.igmpublication.org Impact Factor 5.84 Index Copernicus Value: 83.27 ISSN (e)-2347-176x ISSN (p) 2455-0450 DOI: https://dx.doi.org/10.18535/jmscr/v5i7.47 Original Research Article Tadalafil therapy

More information

A Comparative Study of Efficacy and Safety Between Tamsulosin and Terazosin in the Treatment of Symptomatic Benign Prostatic Hyperplasia

A Comparative Study of Efficacy and Safety Between Tamsulosin and Terazosin in the Treatment of Symptomatic Benign Prostatic Hyperplasia Chattagram Maa-O-Shishu Hospital Medical College Journal Original Article A Comparative Study of Efficacy and Safety Between Tamsulosin and Terazosin in the Treatment of Symptomatic Benign Prostatic Hyperplasia

More information

Benign prostatic hyperplasia By Lynn Gould

Benign prostatic hyperplasia By Lynn Gould Benign prostatic hyperplasia By Lynn Gould Learning objectives After reading this article you should be able to: Identify symptoms suggestive of benign prostatic hyperplasia (BPH). Provide advice to customers

More information

Chapter 3: Results of the Treatment Outcomes Analyses

Chapter 3: Results of the Treatment Outcomes Analyses Chapter 3: Results of the Treatment Outcomes Analyses Introduction To determine the appropriateness of individual therapies, as well as to develop practice recommendations, the American Urological Association

More information

Management of Voiding Problems in Older Men. Dr. John Fenn Consultant, QEH 10 th October, 2005

Management of Voiding Problems in Older Men. Dr. John Fenn Consultant, QEH 10 th October, 2005 Management of Voiding Problems in Older Men Dr. John Fenn Consultant, QEH 10 th October, 2005 Voiding Problems Poor stream Hesitancy Straining Incomplete emptying Intermittent micturition Terminal dribbling

More information

Alpha-BlockerTherapy Can Be Withdrawn in the Majority of Men Following Initial CombinationTherapy with the Dual 5a-Reductase Inhibitor Dutasteride

Alpha-BlockerTherapy Can Be Withdrawn in the Majority of Men Following Initial CombinationTherapy with the Dual 5a-Reductase Inhibitor Dutasteride European Urology European Urology 44 (2003) 461 466 Alpha-BlockerTherapy Can Be Withdrawn in the Majority of Men Following Initial CombinationTherapy with the Dual 5a-Reductase Inhibitor Dutasteride J.

More information

Medical therapy options for aging men with benign prostatic hyperplasia: focus on alfuzosin 10 mg once daily

Medical therapy options for aging men with benign prostatic hyperplasia: focus on alfuzosin 10 mg once daily REVIEW Medical therapy options for aging men with benign prostatic hyperplasia: focus on alfuzosin 10 mg once daily Claus G Roehrborn 1 Raymond C Rosen 2 1 Department of Urology, University of Texas Southwestern

More information

Management of male LUTS in general practice

Management of male LUTS in general practice 17 Management of male LUTS in general practice MARK J. SPEAKMAN AND FAITH MCMEEKIN The initial management of lower urinary tract symptoms in men is usually carried out in primary care. The authors explain

More information

The PSA, Prostate Cancer Screening, and other Prostate Treatment Secrets!

The PSA, Prostate Cancer Screening, and other Prostate Treatment Secrets! The PSA, Prostate Cancer Screening, and other Prostate Treatment Secrets Mark Bieri, MD Dilemmas in the screening for prostate cancer, the treatments for Cap, and other prostate problems What is the PSA?

More information

The PSA, Prostate Cancer Screening, and other Prostate Treatment Secrets! Mark Bieri, MD!

The PSA, Prostate Cancer Screening, and other Prostate Treatment Secrets! Mark Bieri, MD! The PSA, Prostate Cancer Screening, and other Prostate Treatment Secrets! Mark Bieri, MD! Dilemmas in the screening for prostate cancer, the treatments for Cap, and other prostate problems! What is the

More information

Cialis. Cialis (tadalafil) Description

Cialis. Cialis (tadalafil) Description Federal Employee Program 1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 5.40.22 Subject: Cialis Page: 1 of 5 Last Review Date: September 15, 2017 Cialis Description Cialis (tadalafil)

More information

Prostate Artery Embolization

Prostate Artery Embolization Prostate Artery Embolization in the office interventional suite Robert J. Kennedy, M.D. Interventional & Vascular Center Melbourne, Florida The speaker has no financial conflicts of interest to disclose.

More information

Last Review Status/Date: December Summary

Last Review Status/Date: December Summary Section: Surgery Effective Date: January 15, 2016 Subject: Prostatic Urethral Lift Page: 1 of 9 Last Review Status/Date: December 2015 Summary Benign prostatic hyperplasia (BPH) is a common condition in

More information

Medical Therapy for Benign Prostatic Hyperplasia Present and Future Impact

Medical Therapy for Benign Prostatic Hyperplasia Present and Future Impact REPORTS Medical Therapy for Benign Prostatic Hyperplasia Present and Future Impact Muta M. Issa, MD, MBA; Timothy S. Regan, BPharm, RPh, CPh Abstract The purpose of this manuscript is to provide clinicians,

More information

European Urology 48 (2005)

European Urology 48 (2005) European Urology European Urology 48 (2005) 269 276 BPH/Prostatic Diseases Evaluation of Male Sexual Function in Patients with Lower UrinaryTract Symptoms (LUTS) Associated with Benign Prostatic Hyperplasia

More information

Voiding Dysfunction. Hyo Serk Lee, Sae Woong Kim 1, Seung-June Oh 2, Myung-Soo Choo 3, Kyu-Sung Lee

Voiding Dysfunction. Hyo Serk Lee, Sae Woong Kim 1, Seung-June Oh 2, Myung-Soo Choo 3, Kyu-Sung Lee www.kjurology.org http://dx.doi.org/10.4111/kju.2012.53.3.178 Voiding Dysfunction Efficacy and Safety of Tamsulosin for Treating Lower Urinary Tract Symptoms Associated with Benign Prostatic Hyperplasia:

More information

What is the menopause?

What is the menopause? Information for you Alternatives to hormone replacement therapy for symptoms of the menopause Published in December 2011 This information is for you if you are considering alternatives to hormone replacement

More information